Literature DB >> 16034631

[Acneiform skin eruption in patients with metastatic colorectal carcinoma].

K Gethöffer1, L-A Schneider, T Peters, L Weber, K Scharffetter-Kochanek.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16034631     DOI： 10.1007/s00105-005-0999-1

Source DB:  PubMed          Journal:  Hautarzt        ISSN： 0017-8470            Impact factor:   0.751


× No keyword cloud information.
  5 in total

1.  Clinical colorectal cancer: the epidermal growth factor receptor signaling pathway as a chemotherapeutic target.

Authors:  Edward Chu
Journal:  Clin Colorectal Cancer       Date:  2003-02       Impact factor: 4.481

2.  Acneiform eruption induced by epidermal growth factor receptor inhibitors in patients with solid tumours.

Authors:  W Jacot; D Bessis; E Jorda; M Ychou; M Fabbro; J-L Pujol; B Guillot
Journal:  Br J Dermatol       Date:  2004-07       Impact factor: 9.302

Review 3.  Cetuximab: an epidermal growth factor receptor chemeric human-murine monoclonal antibody.

Authors:  Joanne Harding; Barbara Burtness
Journal:  Drugs Today (Barc)       Date:  2005-02       Impact factor: 2.245

4.  Cutaneous side-effects in cancer patients treated with the antiepidermal growth factor receptor antibody C225.

Authors:  K J Busam; P Capodieci; R Motzer; T Kiehn; D Phelan; A C Halpern
Journal:  Br J Dermatol       Date:  2001-06       Impact factor: 9.302

Review 5.  HER1/EGFR inhibitor-associated rash: future directions for management and investigation outcomes from the HER1/EGFR inhibitor rash management forum.

Authors:  Román Pérez-Soler; Jean Pierre Delord; Allan Halpern; Karen Kelly; James Krueger; Bartomeu Massutí Sureda; Joachim von Pawel; Jennifer Temel; Salvatore Siena; Denis Soulières; Leonard Saltz; James Leyden
Journal:  Oncologist       Date:  2005-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.